Niraparib, or a tautomer thereof, optionally in the form of a pharmaceutically acceptable salt, in particular the tosylate or a hydrate, more in particular the tosylate monohydrate

摘要

The present invention relates to combinations of compounds of formula I: and other anti-cancer agents which are useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage and skin senescence and UV-induced skin damage.